Skip to main content
Clinical Trials/NL-OMON51096
NL-OMON51096
Recruiting
Not Applicable

PRospective Evaluation of complete revascularization in patients with multiveSsel disease Excluding chroNic Total occlusions - PRESENT

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
350
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>\= 18 years, \<\=85 years
  • 2\. The patient is an acceptable candidate for treatment with a drug eluting
  • stent in accordance with the applicable guidelines on percutaneous coronary
  • interventions, manufacturer\*s Instructions for Use and the Declaration of
  • 3\. Patient indication, lesion length and vessel diameter of the target
  • lesion(s) are according to the \*Instructions for Use\* that comes with every
  • Resolute Onyx (Zotarolimus\-Eluting stent) system.
  • 4\. The patient is willing and able to cooperate with study procedures and
  • required follow up visits
  • 5\. The subject or legal representative has been informed of the nature of the

Exclusion Criteria

  • 1\. Age \<18 years and \> 85 years.
  • 2\. Single coronary vessel disease.
  • 3\. No left anterior descending lesion.
  • 4\. Patients in cardiogenic shock.
  • 5\. Patients with STEMI.
  • 6\. Presence of a chronic total occlusion (CTO) defined as coronary lesion with
  • Thrombolysis in Myocardial Infarction (TIMI) flow grade 0 on initial
  • angiography present for more than or equal to 3 months.
  • 7\. Left main coronary artery disease
  • 8\. Patients who cannot give informed consent or have a life expectancy of less

Outcomes

Primary Outcomes

Not specified

Similar Trials